July 5, 2026 – Patient Worthy

https://pixabay.com/en/alphabet-soup-letters-soup-eat-2034920/

Grifols Starts Phase 3 Trial for a New, More Convenient Alpha-1 Treatment

Post author:Kathy Devanny
Post published:July 5, 2026
Post category:Alpha-1 antitrypsin deficiency

What Happened? The healthcare company Grifols announced in a recent press release that it has enrolled and dosed the very first patient in a new Phase 3 clinical trial called…

We believe rare disease patients are people, not a diagnosis. Through education, awareness and some humor, we help patients, caregivers and support persons by providing relevant and often inspirational news and stories.

Our goals are to share stories, cultivate strong community, provide the latest medical findings, connect people and pioneer production of patient worthy information. Help us attain these goals by telling us a little bit about yourself!

Let’s Work Together!

Keep Up to Date

Learn More